Reimbursement policies are arguably the single most powerful market determinant for the European Blood Glucose Test Strip sector. In a region where healthcare is predominantly publicly funded, a product's success is not determined by consumer marketing but by its inclusion in national and regional health system formularies. These policies dictate not only the volume of strips a patient is...